{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:07:36Z","timestamp":1791828456583,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TUBITAK"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bioorg.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:42:46Z","timestamp":1538696566000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors"],"prefix":"10.1016","volume":"82","author":[{"given":"Nabih","family":"Lolak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Akocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.10.005_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2018.10.005_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia-a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2018.10.005_b0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2018.10.005_h0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.10.005_h0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.10.005_h0030","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.10.005_h0035","doi-asserted-by":"crossref","first-page":"17792","DOI":"10.1021\/acsami.8b05607","article-title":"pH-Senstive multiligand gold nanoplatform targeting carbonic anhydrase IX enhances the delivery of Doxorubicin to hypoxic tumor spheroids and overcomes the hypoxia-induced chemoresistance","volume":"10","author":"Shabana","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2018.10.005_h0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert OpinDrug Discov."},{"key":"10.1016\/j.bioorg.2018.10.005_h0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0055","series-title":"Targeting Carbonic Anhydrases","first-page":"35","article-title":"Next-generation primary sulfonamide carbonic anhydrase inhibitors","author":"Akocak","year":"2014"},{"key":"10.1016\/j.bioorg.2018.10.005_h0060","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII, and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bioorg.2018.01.022","article-title":"Synthesis and biological evaluation of novel N, N\u2032-Diaryl Cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Akocak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0070","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1021\/acs.jmedchem.6b00492","article-title":"PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas","volume":"59","author":"Akocak","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2008","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Part."},{"key":"10.1016\/j.bioorg.2018.10.005_h0085","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2018.10.005_h0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.10.005_h0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/13543776.2012.698264","article-title":"Sulfoanmides: a patent review (2008\u20132012)","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2018.10.005_h0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005\u20132013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2018.10.005_h0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2018.10.005_b0040","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2018.10.005_h0115","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0120","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_b0050","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.bioorg.2018.10.005_b0055","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bmc.2006.11.028","article-title":"Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives","volume":"15","author":"Zheng","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0135","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2174\/1389557514666140622205904","article-title":"Medicinal chemistry discoveries among 1,3,5-triazines: recent advances (2000\u20132013) as antimicrobial, anti-TB, anti-HIV and antimalarials","volume":"14","author":"Patel","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4172\/2161-0444.1000255","article-title":"A systematic review on antitumor agents with 1,3,5-triazines","volume":"5","author":"Liu","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_b0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejmech.2017.09.035","article-title":"1,3,5-Triazines: a promising scaffald, for anticancer drugs development","volume":"142","author":"Cascioferro","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_b0070","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.005_b0075","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II, and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.005_h0160","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmc.2013.09.031","article-title":"Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties","volume":"21","author":"Ceruso","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0165","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII, and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_b0085","unstructured":"T.K. Brotherton, J.W. Lynn, J. Smith, Isocyanatophenyl sulfonyl isocyanates, US 3454606A, 1969."},{"key":"10.1016\/j.bioorg.2018.10.005_b0090","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.joc.6b00355","article-title":"N-methylamines-synthesis, characterization and physical properties","volume":"10","author":"List","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_b0095","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0185","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1039\/C4CC02346C","article-title":"Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect","volume":"50","author":"Draghici","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2018.10.005_h0190","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/14756366.2017.1386660","article-title":"Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII and IX activators","volume":"32","author":"Akocak","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bioorg.2018.02.015","article-title":"Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Lolak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0200","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2018.1515933","article-title":"Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII and IX inhibitors","author":"Akocak","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem"},{"key":"10.1016\/j.bioorg.2018.10.005_h0205","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.21873\/anticanres.12832","article-title":"Antiproliferative and apoptotic role of novel synthesized Cu(II) complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) benzenesulfonamide in common cancer models","volume":"38","author":"Tuluce","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2018.10.005_h0210","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm021123s","article-title":"Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives","volume":"46","author":"Ilies","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0223-5234(98)80033-0","article-title":"Carbonic anhydrase inhibitors \u2013 Part 49: synthesis of substituted ureido and thioureido derivatives of aromatic\/heterocyclic sulfonamides with increased affinities for isozyme I","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14756366.2016.1254207","article-title":"Microwave-assisted synthesis and bioevaluation of new sulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med., Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/1475636021000010950","article-title":"Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties","volume":"17","author":"Casini","year":"2002","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0230","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/jm001051+","article-title":"Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects","volume":"43","author":"Casini","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.005_h0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastov\u00e1","year":"2004","journal-title":"FEBS Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T05:42:46Z","timestamp":1662183766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":47,"alternative-id":["S0045206818309039"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.005","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}